A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
NCT 04913285 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04913285 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 05894239 Brief Summary This study will evaluate the efficacy and…
Read more arrow_forwardNCT 05487235 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 04449874 Brief Summary This is a Phase I dose-escalation and dose-expansion…
Read more arrow_forwardNCT 06004245 Brief Summary This is a first-in-human, Phase I, open-label, multicenter,…
Read more arrow_forwardNCT 06326411 Brief Summary This is a two-part Phase 1, open label,…
Read more arrow_forwardNCT 06533059 Brief Summary The purpose of this study is to characterize…
Read more arrow_forwardNCT 06760819 Brief Summary Researchers are looking for a better way to…
Read more arrow_forwardNCT 06597721 Brief Summary Adcendo ApS is conducting a phase 1 study…
Read more arrow_forwardNCT 05725291 Brief Summary This first-in-human study will evaluate the Maximum…
Read more arrow_forward